Data and Artificial Intelligence

Modeling the manufacturing process benefits both development and operations.

Automated systems help detect and resolve quality issues.

Boehringer Ingelheim has joined the Quantum Technology and Application Consortium (QUTAC) as a founding member.

The Module Type Package standard is now supported in Emerson’s DCS and PLCs.

Technology advances and pandemic environment drive increased use of automation and digital tools.

After Brexit there is an increased risk of the UK being exposed to counterfeit medicines, but regulations implementing blockchain as infrastructure technology could be the answer.

A digital system makes real-time inventory, production, distribution, and shipping information readily accessible.

Integration of Brooks Life Sciences BioStore III automated storage and inventory monitoring solution with Cytiva’s Chronicle software will improve traceability, process control, and monitoring capabilities.

Sharing process insights across the stages of drug development improves tech transfer.

Honeywell’s project team has remotely and efficiently migrated Richter Gedeon’s process control system with limited onsite staffing and resources.

Sanofi’s Digitally Enabled Integrated Continuous Biomanufacturing Facility in Framingham, MA was named the Overall Award winner at the ISPE virtual annual meeting.

At the 2020 Bio/Pharma Virtual Congress, experts discuss how artificial intelligence and machine learning are used to gather and process real-time manufacturing data.

Successful migrations require careful planning to meet business needs and maintain data integrity.

Consider modular automation and cybersecurity when modernizing manufacturing processes.

Edge-AI technology will enable Industry 4.0 automation in pharmaceutical manufacturing.

Automation and tools for remote monitoring are finding increased use as pharmaceutical manufacturing adapts to pandemic restrictions.

Ongoing and emerging cyber-risks to legacy operational technology systems in bio/pharmaceutical manufacturing must be addressed.

The register supports cross-functional teams of chemists and biologists in developing non-natural, chemically-modified therapeutics for drug discovery.

Honeywell Forge Cybersecurity Suite’s improved industrial-grade remote access and added protection and risk monitoring aids remote operations.

Quartic.ai and Bright Path Laboratories have agreed to develop an artificial intelligence (AI)-powered continuous manufacturing platform for APIs and other small-molecule drugs using Bright Path Labs’ continuous bioreactor and the Quartic.ai smart manufacturing technology.

Remote, machine health monitoring services reduce the need for on-site visits.

MilliporeSigma’s Bio4C Software Suite combines process control, analytics, and plant-level automation.

A comprehensive turnkey system based on LabVantage’s laboratory information management system platform allows laboratories to implement COVID-19 biobanking, testing, and research.

Analyzing process and equipment data provides insights that can improve quality and productivity of pharmaceutical manufacturing.

Enhancements to Augury’s AI-based machine health platform include new capabilities and collaboration tools for personnel working remotely.

Emerson’s Mimic Field 3D program offers an immersive simulation using a digital twin as an alternative to training on physical equipment.

Vein-to-vein programs are focusing on data access and traceability.

CDMOs must consider challenges associated with the complexity of contract pharmaceutical manufacturing when approaching digitalization projects.

Data collected through the Industrial Internet of Things enable predictive maintenance.

Sartorius and the German Research Center for Artificial Intelligence have established a research laboratory for AI in the biopharmaceutical industry.